- Home
- SOHU vs LRMR Comparison
SOHU vs LRMR Comparison
Compare SOHU & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHU
- LRMR
- Stock Information
- Founded
- SOHU 1996
- LRMR N/A
- Country
- SOHU China
- LRMR United States
- Employees
- SOHU N/A
- LRMR N/A
- Industry
- SOHU EDP Services
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- SOHU Technology
- LRMR Health Care
- Exchange
- SOHU Nasdaq
- LRMR Nasdaq
- Market Cap
- SOHU 439.1M
- LRMR 360.3M
- IPO Year
- SOHU 2000
- LRMR N/A
- Fundamental
- Price
- SOHU $14.89
- LRMR $4.27
- Analyst Decision
- SOHU Strong Buy
- LRMR Strong Buy
- Analyst Count
- SOHU 1
- LRMR 7
- Target Price
- SOHU $20.00
- LRMR $16.71
- AVG Volume (30 Days)
- SOHU 50.6K
- LRMR 4.5M
- Earning Date
- SOHU 11-11-2025
- LRMR 11-14-2025
- Dividend Yield
- SOHU N/A
- LRMR N/A
- EPS Growth
- SOHU N/A
- LRMR N/A
- EPS
- SOHU 4.10
- LRMR N/A
- Revenue
- SOHU $548,588,000.00
- LRMR N/A
- Revenue This Year
- SOHU N/A
- LRMR N/A
- Revenue Next Year
- SOHU $2.29
- LRMR N/A
- P/E Ratio
- SOHU $3.62
- LRMR N/A
- Revenue Growth
- SOHU N/A
- LRMR N/A
- 52 Week Low
- SOHU $7.79
- LRMR $1.61
- 52 Week High
- SOHU $16.45
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- SOHU 50.71
- LRMR 50.82
- Support Level
- SOHU $14.11
- LRMR $3.87
- Resistance Level
- SOHU $14.68
- LRMR $4.46
- Average True Range (ATR)
- SOHU 0.46
- LRMR 0.31
- MACD
- SOHU 0.02
- LRMR -0.05
- Stochastic Oscillator
- SOHU 66.87
- LRMR 36.44
About SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.